ArticleOncotarget2017

Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.

Patricia Macanas-Pirard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.